A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 10
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : VASP
Long Form : vasodilator-associated stimulated phosphoprotein
No. Year Title Co-occurring Abbreviation
2021 Carbamazepine Induces Platelet Apoptosis and Thrombocytopenia Through Protein Kinase A. Bad, PKA
2020 Head-to-Head Comparison of Consensus-Recommended Platelet Function Tests to Assess P2Y12 Inhibition-Insights for Multi-Center Trials. ICC
2016 P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC study. LD, PCI, PRI, PRU
2014 The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER study. AMs, BMI, BSA, BW, Clop-75, MPA, Pras-10, Pras-5, PRI
2013 Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation to assess P2Y12 -inhibition after ticagrelor intake. PRI
2013 Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein phosphorylation to assess P2Y12 -inhibition after ticagrelor intake. PRI
2013 Identification of poor response to P2Y12 inhibitors in ACS patients with a new ELISA-based vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation assay. ACS, HPR, LTA, PRI, ROC, VN-P2Y12
2013 Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients. CAD, LTA, MPA, NE, PD, PKs, VE, VN-P2Y12
2012 Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trial. CAD, HBW, HPR, LBW, LTA, MPA
10  2011 Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y(12) inhibition. ADP, FC, PRI